Residual rates of reflux and obstruction and their correlation to post-thrombotic syndrome in a randomized study on catheter-directed thrombolysis for deep vein thrombosis

Journal of Vascular Surgery: Venous and Lymphatic Disorders

Volumn 2, Issue 2, 2014, Pages 123-130

  Haig, Ylva ^a,b   Enden, Tone ^a,b   Slagsvold, Carl Erik ^a   Sandvik, Leiv ^a   Sandset, Per Morten ^a,b   Kløw, Nils Einar ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; CATHETER DIRECTED THROMBOLYSIS; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPRESSION STOCKING; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PROCEDURES; MULTICENTER STUDY; OPEN STUDY; PLETHYSMOGRAPHY; POSTTHROMBOSIS SYNDROME; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT PLANNING; VASCULAR PATENCY; VEIN OCCLUSION; VENOUS REFLUX;

EID: 84896314717     PISSN: 2213333X     EISSN: 22133348     Source Type: Journal    
DOI: 10.1016/j.jvsv.2013.10.054     Document Type: Article

References (34)

1. Kahn S.R. The post-thrombotic syndrome: progress and pitfalls. Br J Haematol 2006, 134:357-365.
2. Kahn S.R., Hirsch A., Shrier I. Effect of postthrombotic syndrome on health-related quality of life after deep venous thrombosis. Arch Intern Med 2002, 162:1144-1148.
3. Enden T., Haig Y., Klow N.E., Slagsvold C.E., Sandvik L., Ghanima W., et al. Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial. Lancet 2012, 379:31-38.
4. Enden T., Klow N.E., Sandvik L., Slagsvold C.E., Ghanima W., Hafsahl G., et al. Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. JThromb Haemost 2009, 7:1268-1275.
5. Haig Y., Enden T., Slagsvold C.E., Sandvik L., Sandset P.M., Klow N.E. Determinants of early and long-term efficacy of catheter-directed thrombolysis in proximal deep vein thrombosis. JVasc Interv Radiol 2013, 24:17-24. quiz: 26.
6. Kuo W.T. Optimizing catheter-directed thrombolysis for acute deep vein thrombosis: validating the open vein hypothesis. JVasc Interv Radiol 2013, 24:24-26.
7. Franzeck U.K., Schalch I., Jager K.A., Schneider E., Grimm J., Bollinger A. Prospective 12-year follow-up study of clinical and hemodynamic sequelae after deep vein thrombosis in low-risk patients (Zurich study). Circulation 1996, 93:74-79.
8. Killewich L.A., Martin R., Cramer M., Beach K.W., Strandness D.E.J. An objective assessment of the physiologic changes in the postthrombotic syndrome. Arch Surg 1985, 120:424-426.
9. Johnson B.F., Manzo R.A., Bergelin R.O., Strandness D.E.J. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six-year follow-up. JVasc Surg 1995, 21:307-312. discussion: 313.
10. Akesson H., Brudin L., Dahlstrom J.A., Eklof B., Ohlin P., Plate G. Venous function assessed during a 5-year period after acute ilio-femoral venous thrombosis treated with anticoagulation. Eur J Vasc Surg 1990, 4:43-48.
11. Baekgaard N., Broholm R., Just S., Jorgensen M., Jensen L.P. Long-term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis. Eur J Vasc Endovasc Surg 2010, 39:112-117.
12. Elsharawy M., Elzayat E. Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial. Eur J Vasc Endovasc Surg 2002, 24:209-214.
13. Enden T., Sandvik L., Klow N.E., Hafsahl G., Holme P.A., Holmen L.O., et al. Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis-the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771). Am Heart J 2007, 154:808-814.
14. Kearon C., Akl E.A., Comerota A.J., Prandoni P., Bounameaux H., Goldhaber S.Z., et al. Antithrombotic therapy for VTE Disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012, 141:e419S-e494S.
15. Coleridge-Smith P., Labropoulos N., Partsch H., Myers K., Nicolaides A., Cavezzi A. Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs-UIP consensus document. Part I. Basic principles. Eur J Vasc Endovasc Surg 2006, 31:83-92.
16. Nicolaides A.N. Investigation of chronic venous insufficiency: a consensus statement (France, March 5-9, 1997). Circulation 2000, 102:E126-E163.
17. Stranden E., Laerum F. [Plethysmographic diagnosis of deep vein thrombosis]. Tidsskr Nor Laegeforen 1982, 102:321-323.
18. Villalta S., Bagatella P., Piccioli A., Lensing A.W., Prins M.H., Prandoni P. Assessment of validity and reproducibility of a clinical scale for the postthrombotic syndrome. Haemostasis 1994, 24:158.
19. Prandoni P., Kahn S.R. Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol 2009, 145:286-295.
20. Kahn S.R., Shrier I., Julian J.A., Ducruet T., Arsenault L., Miron M.J., et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008, 149:698-707.
21. Tick L.W., Doggen C.J., Rosendaal F.R., Faber W.R., Bousema M.T., Mackaay A.J., et al. Predictors of the post-thrombotic syndrome with non-invasive venous examinations in patients 6 weeks after a first episode of deep vein thrombosis. JThromb Haemost 2010, 8:2685-2692.
22. Roumen-Klappe E.M., den Heijer M., Janssen M.C., van der Vleuten C., Thien T., Wollersheim H. The post-thrombotic syndrome: incidence and prognostic value of non-invasive venous examinations in a six-year follow-up study. Thromb Haemost 2005, 94:825-830.
23. van Dongen C.J., Prandoni P., Frulla M., Marchiori A., Prins M.H., Hutten B.A. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. JThromb Haemost 2005, 3:939-942.
24. Kahn S.R., Shbaklo H., Lamping D.L., Holcroft C.A., Shrier I., Miron M.J., et al. Determinants of health-related quality of life during the 2 years following deep vein thrombosis. JThromb Haemost 2008, 6:1105-1112.
25. Vedantham S., Grassi C.J., Ferral H., Patel N.H., Thorpe P.E., Antonacci V.P., et al. Reporting standards for endovascular treatment of lower extremity deep vein thrombosis. JVasc Interv Radiol 2009, 20:S391-S408.
26. Sarin S., Sommerville K., Farrah J., Scurr J.H., Coleridge Smith P.D. Duplex ultrasonography for assessment of venous valvular function of the lower limb. Br J Surg 1994, 81:1591-1595.
27. Laiho M.K., Oinonen A., Sugano N., Harjola V.P., Lehtola A.L., Roth W.D., et al. Preservation of venous valve function after catheter-directed and systemic thrombolysis for deep venous thrombosis. Eur J Vasc Endovasc Surg 2004, 28:391-396.
28. Young L., Ockelford P., Milne D., Rolfe-Vyson V., Mckelvie S., Harper P. Post-treatment residual thrombus increases the risk of recurrent deep vein thrombosis and mortality. JThromb Haemost 2006, 4:1919-1924.
29. Ageno W., Piantanida E., Dentali F., Steidl L., Mera V., Squizzato A., et al. Body mass index is associated with the development of the post-thrombotic syndrome. Thromb Haemost 2003, 89:305-309.
30. Biguzzi E., Mozzi E., Alatri A., Taioli E., Moia M., Mannucci P.M. The post-thrombotic syndrome in young women: retrospective evaluation of prognostic factors. Thromb Haemost 1998, 80:575-577.
31. Galanaud J.P., Holcroft C.A., Rodger M.A., Kovacs M.J., Betancourt M.T., Wells P.S., et al. Predictors of post-thrombotic syndrome in a population with a first deep vein thrombosis and no primary venous insufficiency. JThromb Haemost 2013, 11:474-480.
32. Prandoni P., Lensing A.W., Cogo A., Cuppini S., Villalta S., Carta M., et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996, 125:1-7.
33. Chitsike R.S., Rodger M.A., Kovacs M.J., Betancourt M.T., Wells P.S., Anderson D.R., et al. Risk of post-thrombotic syndrome after subtherapeutic warfarin anticoagulation for a first unprovoked deep vein thrombosis: results from the REVERSE study. JThromb Haemost 2012, 10:2039-2044.
34. Kahn S.R. Measurement properties of the Villalta scale to define and classify the severity of the post-thrombotic syndrome. JThromb Haemost 2009, 7:884-888.